Altering the course of disease in multiple sclerosis: many large steps forward.
Departamento de Neurologia Neuroimunologia e Doenças Neurológicas Raras, Universidade Metropolitana de Santos, Santos, SP, BR.
Yara Dadalti
YD
Fragoso
D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab / Q000627:therapeutic use*
D007155:Immunologic Factors; D000069442:Natalizumab